Economic Considerations in the Management of Heart Failure
Our co-hosts interview Paul Heidenreich, MD, FHFSA a co-author of the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure about economic considerations in the management of HF. On "From Failure to Function", Priya dives into the late breaking trials from ACC.23 and Michael reviews three papers on HFpEF on HF Rounds.
Michael Beasley, MD, Assistant Professor of Medicine at the Yale New Haven Hospital @MHBeasleyMD
Priya Umapathi, MD Assistant Professor in the Division of Cardiology & Advanced Heart Failure and Heart Transplant Cardiologist at Johns Hopkins Hospital @priyaumapathi
Paul Heidenreich, MD, FHFSA Professor and Vice-Chair for Quality in the Department of Medicine at the Stanford University School of Medicine @paheidenreich
- Heart Failure With Preserved Ejection Fraction: A Review
Redfield MM, Borlaug BA.
Originally published 14 March 2023 http://dx.doi.org/10.1001/jama.2023.2020 JAMA 2023;329(10):827–838.
- Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction
Chieng D, Sugumar H, Segan L, et al.
https://doi.org/10.1016/j.jchf.2023.01.008 J Am Coll Cardiol HF. 2023
- Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction: The myPACE Randomized Clinical Trial.
Infeld M, Wahlberg K, Cicero J, et al.
Originally published 1 February 2023 https://doi.org/10.1001/jamacardio.2022.5320 JAMA Cardiol. 2023;8(3):213–221.